Robert-Bosch-Krankenhaus

Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes (2021) Polhemus A, Ortiz LD, Brittain G, Chynkiamis N, Salis F, Gaßner H, Gross M, et al. Journal article, Review article Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis (2021) Escala-Garcia M, Canisius S, Keeman R, Beesley J, Anton-Culver H, Arndt V, Augustinsson A, et al. Journal article Myocarditis in athletes: A clinical perspective (2021) Halle M, Binzenhoefer L, Mahrholdt H, Schindler MJ, Esefeld K, Tschoepe C Journal article, Review article Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia (2021) Stasik S, Eckardt JN, Kramer M, Roellig C, Kraemer A, Scholl S, Hochhaus A, et al. Journal article Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, et al. Journal article Mendelian randomisation study of smoking exposure in relation to breast cancer risk (2021) Park HA, Neumeyer S, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, et al. Journal article Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element (2021) Baxter JS, Johnson N, Tomczyk K, Gillespie A, Maguire S, Brough R, Fachal L, et al. Journal article Short distance analysis of the 400-meter walk test of mobility in community-dwelling older adults (2021) Krumpoch S, Lindemann U, Becker C, Sieber C, Freiberger E Journal article Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? (2021) Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, et al. Journal article Loss-of-function mutations of bcor are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia (2021) Eckardt JN, Stasik S, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, et al. Journal article